The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125506201 12550620 1 I 20151002 20160707 20160712 20160712 EXP CH-ALLERGAN-1662543US ALLERGAN 37.00 YR F Y 0.00000 20160712 CN CH CH

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125506201 12550620 1 PS BOTOX ONABOTULINUMTOXINA 1 Intramuscular 0.1 ML, SINGLE U 103000 .1 ML POWDER FOR INJECTION QD
125506201 12550620 2 SS BOTOX ONABOTULINUMTOXINA 1 Intramuscular 0.1 ML, SINGLE U 103000 .1 ML POWDER FOR INJECTION QD
125506201 12550620 3 SS BOTOX ONABOTULINUMTOXINA 1 Intramuscular 0.1 ML, SINGLE U 103000 .1 ML POWDER FOR INJECTION QD
125506201 12550620 4 SS BOTOX ONABOTULINUMTOXINA 1 Intramuscular 0.2 ML, SINGLE U 103000 .2 ML POWDER FOR INJECTION QD
125506201 12550620 5 SS BOTOX ONABOTULINUMTOXINA 1 Intramuscular 0.2 ML, SINGLE U 103000 .2 ML POWDER FOR INJECTION QD
125506201 12550620 6 SS BOTOX ONABOTULINUMTOXINA 1 Intramuscular 0.2 ML, SINGLE U 103000 .2 ML POWDER FOR INJECTION QD
125506201 12550620 7 SS BOTOX ONABOTULINUMTOXINA 1 Intramuscular 0.2 ML, SINGLE U 103000 .2 ML POWDER FOR INJECTION QD
125506201 12550620 8 SS BOTOX ONABOTULINUMTOXINA 1 Intramuscular 0.1 ML, SINGLE U 103000 .1 ML POWDER FOR INJECTION QD
125506201 12550620 9 SS BOTOX ONABOTULINUMTOXINA 1 Intramuscular 0.1 ML, SINGLE U 103000 .1 ML POWDER FOR INJECTION QD
125506201 12550620 10 SS BOTOX ONABOTULINUMTOXINA 1 Intramuscular 0.1 ML, SINGLE U 103000 .1 ML POWDER FOR INJECTION QD
125506201 12550620 11 SS BOTOX ONABOTULINUMTOXINA 1 Intramuscular 0.1 ML, SINGLE U 103000 .1 ML POWDER FOR INJECTION QD
125506201 12550620 12 SS BOTOX ONABOTULINUMTOXINA 1 Intramuscular 0.5 ML, SINGLE U 103000 .5 ML POWDER FOR INJECTION QD
125506201 12550620 13 SS BOTOX ONABOTULINUMTOXINA 1 Intramuscular 0.5 ML, SINGLE U 103000 .5 ML POWDER FOR INJECTION QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125506201 12550620 1 Cervicogenic headache

Outcome of event

Event ID CASEID OUTC COD
125506201 12550620 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125506201 12550620 Dysphagia
125506201 12550620 Muscular weakness
125506201 12550620 Myalgia
125506201 12550620 Off label use
125506201 12550620 Pain of skin
125506201 12550620 Sleep disorder

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125506201 12550620 1 20150929 20150929 0
125506201 12550620 2 20150929 20150929 0
125506201 12550620 3 20150929 20150929 0
125506201 12550620 4 20150929 20150929 0
125506201 12550620 5 20150929 20150929 0
125506201 12550620 6 20150929 20150929 0
125506201 12550620 7 20150929 20150929 0
125506201 12550620 8 20150929 20150929 0
125506201 12550620 9 20150929 20150929 0
125506201 12550620 10 20150929 20150929 0
125506201 12550620 11 20150929 20150929 0
125506201 12550620 12 20150929 20150929 0
125506201 12550620 13 20150929 20150929 0